scholarly journals Signal Transducer and Activator of Transcription 3 Mutation with Invasive Eosinophilic Disease

2012 ◽  
Vol 3 (2) ◽  
pp. ar.2012.3.0035 ◽  
Author(s):  
Kara Crosby ◽  
David Swender ◽  
Leah Chernin ◽  
Said Hafez-Khayyata ◽  
Hans Ochs ◽  
...  

Hyper-IgE syndrome (HIES), or Jobs disease, is a rare immunologic disorder characterized by the triad of staphylococcal abscesses, pneumonia with pneumatocele formation, and elevated IgE. It has been shown to have multiple modes of inheritance, autosomal dominant being more common than autosomal recessive, with sporadic cases as well. A mutation in signal transducer and activator of transcription 3 (STAT3) gene has been linked to the development of the sporadic and dominant forms of HIES. Peripheral eosinophilia, typically greater than two standard deviations from the normal population, is often seen in association with HIES. Despite these elevated levels of blood eosinophils, there have been no reported cases of invasive eosinophilic disease, such as eosonophilic esophagitic. Here we report the first description, to our knowledge, of a patient with HIES with a STAT3 mutation involving exon 12, Thr389Ile, and invasive eosinophilic disease of the esophagus. STAT3 modulates the expression of several genes that control central cell processes such as growth and death in response to external soluble stimuli. A mutation in the STAT3 molecule may affect the eosinophil's response to IL-5 and thus reduce the chemotaxic ability of those cells to migrate into tissues. This may then explain the paucity of eosinophilic infiltrative disease in patients with STAT3 mutations. The level of eosinophilic involvement may be related to the site or type of mutation within the STAT3 molecule. As more data are collected, we may be able to assess whether certain mutations dictate different clinical outcomes, which could prove helpful in directing therapy.

2012 ◽  
Vol 129 (2) ◽  
pp. 559-562.e2 ◽  
Author(s):  
Almut Meyer-Bahlburg ◽  
Ellen D. Renner ◽  
Stacey Rylaarsdam ◽  
Janine Reichenbach ◽  
Lena F. Schimke ◽  
...  

2010 ◽  
Vol 47 (7-8) ◽  
pp. 1629-1634 ◽  
Author(s):  
Anastasios D. Papanastasiou ◽  
Stefanos Mantagos ◽  
Dimitrios A. Papanastasiou ◽  
Ioannis K. Zarkadis

2010 ◽  
Vol 2010 ◽  
pp. 1-5 ◽  
Author(s):  
Lixin Xie ◽  
Xiaoxiang Hu ◽  
Yang Li ◽  
Weihua Zhang ◽  
Liang'an Chen

Hyper-immunoglobulin E syndromes (HIES) including compound primary immunodeficiency and nonimmunological abnormalities are characterized by extremely high serum IgE levels, eosinophilia, eczema, susceptibility to infections, distinctive facial appearance, retention of deciduous teeth, cyst-forming pneumonias, and skeletal abnormalities. Itis reported that some cases of familial HIES are relative to autosomal dominant or recessive inheritance, but most cases are sporadic, and result from mutations in the human signal transducer and activator of transcription 3 (STAT3) gene. In this paper, we firstly report a young man diagnosed of Hyper-IgE syndrome with STAT3 mutation in Mainland China, and investigate the autosomal dominant trait of his family members.


2019 ◽  
Vol 23 (4) ◽  
pp. 306-311
Author(s):  
Jefferson Terry ◽  
Sylvie Langlois ◽  
Rosemarie Rupps ◽  
Harinder Gill

Activating heterozygous germline mutations in the signal transducer and activator of transcription 3 ( STAT3) gene are associated with the rare autoimmune disorder autoimmune disease, multisystem, infantile onset (ADMIO). The phenotype of ADMIO is typified by hypogammaglobulinemia and onset of autoimmune phenomena during early childhood that include diabetes and autoimmune enteritis. This case report describes in utero onset of precocious lymphocyte maturation, autoimmune enteropathy-like inflammation, and proximal renal tubular dysplasia associated with a novel de novo heterozygous STAT3 mutation. The findings expand the phenotype associated with activating STAT3 mutations and suggest that the impact of the immunological abnormalities associated with ADMIO can begin prior to birth.


2011 ◽  
Vol 208 (7) ◽  
pp. 1359-1366 ◽  
Author(s):  
Camilla Pilati ◽  
Mohamed Amessou ◽  
Michel P. Bihl ◽  
Charles Balabaud ◽  
Jeanne Tran Van Nhieu ◽  
...  

Inflammatory hepatocellular adenomas (IHCAs) are benign liver tumors. 60% of these tumors have IL-6 signal transducer (IL6ST; gp130) mutations that activate interleukin 6 (IL-6) signaling. Here, we report that 12% of IHCA subsets lacking IL6ST mutations harbor somatic signal transducer and activator of transcription 3 (STAT3) mutations (6/49). Most of these mutations are amino acid substitutions in the SH2 domain that directs STAT3 dimerization. In contrast to wild-type STAT3, IHCA STAT3 mutants constitutively activated the IL-6 signaling pathway independent of ligand in hepatocellular cells. Indeed, the IHCA STAT3 Y640 mutant homodimerized independent of IL-6 and was hypersensitive to IL-6 stimulation. This was associated with phosphorylation of tyrosine 705, a residue required for IL-6–induced STAT3 activation. Silencing or inhibiting the tyrosine kinases JAK1 or Src, which phosphorylate STAT3, impaired constitutive activity of IHCA STAT3 mutants in hepatocellular cells. Thus, we identified for the first time somatic STAT3 mutations in human tumors, revealing a new mechanism of recurrent STAT3 activation and underscoring the role of the IL-6–STAT3 pathway in benign hepatocellular tumorigenesis.


Sign in / Sign up

Export Citation Format

Share Document